SynthesisMedicine2018

Are phosphodiesterase type 5 inhibitors associated with increased risk of melanoma?: A systematic review and meta-analysis.

Shijian Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.